F

Forte Biosciences
D

FBRX

76.830
USD
-0.03
(-0.04%)
مغلق
حجم التداول
8,163
الربح لكل سهم
-4
العائد الربحي
-
P/E
-17
حجم السوق
1,631,030,754
أصول ذات صلة المقالات
المزيد

العنوان: Forte Biosciences Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.